HKUEMS :: Event Details

Days of Molecular Medicine (DMM) 2018 : “Emerging Asian Epidemic of Cancer and Heart Disease”.
posted by Dr. Li Dak-Sum Research Centre for HKU and Public
Event Type: Public Lecture/Forum/Seminar/Workshop/Conference/Symposium
Event Nature: Medical & Health Care

Event Details

Date: 1 & 2 March 2018
Time: 8:00a.m. - 4:30p.m.
Venue: Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong

Over the past 17 years, the DMM conferences have been one of the most prestigious international events dedicated to promoting translational science and molecular medicine. The meetings are designed to break new ground in areas that are both timely and critical to the advancement of translational science. The impact of DMM is amplified by participation of senior editors of NEJM, Nature Biotechnology, and Science Translational Medicine, all of whom are confirmed as co-chairs, along with several members of the Nobel Assembly at KI.

The 2018 conference aims to highlight how new technologies, the study of unique patient populations, and new academic-foundations-private sector partnerships, are aligning to fight the global increase of cancer and cardiovascular diseases in a way that is clearly beyond the conventional thinking of pandemics, tropical illnesses, and infectious diseases.

A dramatic rise in cancer has engulfed the entire Asian region, driven by aging, environmental concerns, unique dietary/nutritional norms, and genetic predispositions for unique forms of the disease. Heart disease is expanding exponentially, largely due to the increased prevalence of obesity and associated Type II diabetes, with an extraordinarily high incidence of stroke, and unique genetic susceptibility to statin intolerance. The volume of diseases in the relatively uniform genetic background of China holds great promise for uncovering new insights into these important human diseases. Meanwhile, scientific advances ranging from liquid biopsies, cancer genetics, the development of NHP and other large animal models for testing regenerative therapeutic strategies, new genetically engineered NHP and pig models, mRNA cancer vaccines, CAR-T cell therapy for leukemia, and a host of new technologies hold great promise. Research support for developing new therapeutic approaches has increased dramatically in China, which fosters a unique Asian perspective where cost-effectiveness will be critical to allow widespread access. Biotechnology and innovation are likely to blossom in this part of the world in the coming decade, particularly as China becomes an increasingly important market for cancer and heart drugs. In this regard, this year's program includes a roundtable discussion on promoting innovation via new partnerships with foundations, private sector, and academia, with several notable leaders with direct interests in the region presenting diverse viewpoints. The DMM 2018 keynote speaker is Victor Dzau, MD, the President of the national Academy of Medicine (USA) and a leader in cardiovascular science and medicine, and a native of Hong Kong. Several other notable chairs and speakers are attending, please find the preliminary agenda for details.

LanguageEnglish
Session 1DMM 2018 Day 1 - Welcome & Keynote
01/03/2018 08:00-08:45
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Programmeclick to view
08:00 to 08:05 Welcome Ken CHIEN (Professor, Karolinska Institutet) and Gabriel LEUNG (Dean, Li Ka Shing Faculty of Medicine, The University of Hong Kong)
08:05 to 08:45 Keynote Victor DZAU (President, National Academy of Medicine, USA) The Emerging Global Health Epidemic of Cancer and Cardiovascular/Metabolic Disease
Session 2DMM 2018 Day 1 - Cardiovascular and Metabolic Diseases in China
01/03/2018 08:45-13:55
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Descriptionshow details
Chairs: Rui-Ping XIAO (Director, Institute of Molecular Medicine, Peking University/Associate Editor New England Journal of Medicine)and David TANCREDI (Executive Director, Fondation Leducq)
Programmeclick to view
08:45 to 09:20 Emerging epidemic of cancer and cardiovascular disease in China Zhengming CHEN (Co-director of China Oxford Centre for International Health Research)
09:20 to 09:55 New Therapeutic Pathways for Metabolic syndrome Rui-Ping XIAO (Director, Institute of Molecular Medicine, Peking University/Associate Editor New England Journal of Medicine)
09:55 to 10:30 VEGF modRNA: First Time in Human Studies of a Therapeutic Chemically Modified mRNA Li-Ming GAN (Medical Science Director, Early Clinical Development, Astrazeneca)
10:30 to 10:45 Break
10:45 to 11:20 TBD
11:20 to 11:55 Molecular Mechanisms of Vascular Malformations Lars JAKOBSSON (Assistant Professor, Karolinska Institutet)
11:55 to 12:30 3-D Printing and In Utero diagnosis of congenital heart disease Jinfen LIU (Chief Physician, Cardiothoracic Surgery Department, Shanghai Childrens Medical Center)
12:30 to 13:20 Lunch
13:20 to 13:55 Stem Cell models for Personalized Cardiac Therapeutics Karl-Ludwig LAUGWITZ (Professor, Chief of Cardiovascular Medicine, Technical University of Munich)
Session 3DMM 2018 Day 1 - Cancer Genetics and Diagnostics
01/03/2018 13:55-16:30
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Descriptionshow details
Chairs: Jussi TAIPALE (Professor,Karolinska Institutet/Cambridge, UK) and Orla SMITH (Editor, Science Translational Medicine)
Programmeclick to view
13:55 to 14:30 Epidemiology of Cancer in China Gabriel LEUNG (Dean, Li Ka Shing Faculty of Medicine, HKU)
14:30 to 15:05 Systems Biology of Cancer Jussi TAIPALE (Professor,Karolinska Institutet/Cambridge, UK)
15:05 to 15:20 Break
15:20 to 15:55 New insights into Nasopharyngeal Carcinoma Maria LUNG (Chair Professor, Department of Clinical Oncology, HKU)
15:55 to 16:30 TCRs, Checkpoint inhibitors, and Cancer Tak MAK (University Professor, Princess Margaret Cancer Centre, UHN)
Session 4DMM 2018 Day 2 - Biologically Targeted Cancer Therapeutics
02/03/2018 08:00-11:10
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Descriptionshow details
Chairs: Luca GIANNI (Director, Department of Medical Oncology, President Fondazione Michelangelo), Patrick DELAVAULT (Senior VP, Chief Medical Officer, IPSEN) and Maria MASUCCI (Deputy Vice Chancellor for International Affairs, Karolinska Institutet
Programmeclick to view
08:00 to 08:35 RECQL mutations and breast cancer in Chinese populations Ava KWONG (Assistant Dean, Chief of Breast Surgery Division, The University of Hong Kong)
08:35 to 09:10 Next Generation Biologically Targeted therapy for Lung Cancer Tony MOK (Chairman, Department of Clinical Oncology, CUHK)
09:10 to 09:25 Break
09:25 to 10:00 Novel cancer therapy by targeting missense and nonsense mutant TP53 Klas WIMAN (Professor, Karolinska Institutet)
10:00 to 10:35 Early detection of cancer by circulating DNA Dennis LO (Director, Li Ka Shing Institute of Health Sciences, HKU/Professor, CUHK)
10:35 to 11:10 Designer Drugs for CNS Tumors: Crossing the Blood-Brain Barrier Xiaolin ZHANG (CEO, Dizal/Joint Astrazeneca-China Newcoirector, Innovation Center China, AstraZeneca)
Session 5DMM 2018 Day 2 - Biotechnology Innovation: The Academic-NPO-Private Sector Axis
02/03/2018 11:10-12:20
Descriptionshow details
Chairs/Moderators: Ken CHIEN (Professor, Karolinska Institutet); Paul TAM (Provost, The University of Hong Kong); Andy MARSHALL (Editor in Chief, Nature Biotechnology)
Programmeclick to view
11:10 to 11:30 Keynote Ole Petter OTTERSEN (Chancellor and President, Karolinska Institutet) Rethinking Innovation in Academic Medical Centers
11:30 to 12:20 Lunch
Session 6DMM 2018 Day 2 - Roundtable: NPOs and Innovation in Cancer and Heart Disease
02/03/2018 12:30-14:00
Programmeclick to view
12:30 to 12:45 Luca GIANNI (Director of the Department of Medical Oncology, President,Fondazione Michelangelo)
12:45 to 13:00 David FOSTER (Director, Croucher Foundation)
13:00 to 13:15 David TANCREDI (Executive Director, Fondation Leducq)
13:15 to 13:45 Group Roundtable Discussion
13:45 to 14:00 Break
Session 7DMM 2018 Day 2 - Roundtable: Private Sector and Innovation in China
02/03/2018 14:00-15:50
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Programmeclick to view
14:00 to 14:20 Overview: Andy MARSHALL (Editor in Chief, Nature Biotechnology)
14:20 to 14:35 Lorenz MAYR (Chief Technology Officer, GE Life Sciences)
14:35 to 14:50 Tony MUSLIN (VP and Global Head of CV/Metabolic Disease, Sanofi)
14:50 to 15:05 Michael SJÖSTRÖM (Co-Founder and CIO Geneva/Montreal/HKG, Sectoral Asset Management)
15:05 to 15:20 Xiaolin ZHANG (CEO, Dizal/Joint Astrazeneca-China Newcoirector, Innovation Center China, AstraZeneca)
15:20 to 15:50 Group Roundtable Discussion
Session 8DMM 2018 Day 2 - Closing Remarks
02/03/2018 15:50-16:00
at Cheung Kung Hai Lecture Theatre, G/F, William M.W. Mong Block, Faculty of Medicine Building, 21 Sass
Descriptionshow details
Maria MASUCCI (Deputy Vice Chancellor for International Affairs, Karolinska Institutet)

Registration Instruction

Registration is open from 20/11/2017 15:00(HKT) to 23/02/2018 16:00(HKT) on a first-come-first-served basis. The registration quota for this event is 250. Registrants will be placed on a waiting list if the registration quota is reached.

Register

Contact Information

Should you have any enquiries, please feel free to contact Manager Thomas Leon by email at tleon@hku.hk or by phone at 2831 5391.